CureVac NV (CVAC)
3.13
+0.36
(+13.00%)
USD |
NASDAQ |
May 03, 16:00
3.13
0.00 (0.00%)
After-Hours: 19:07
CureVac Cash from Operations (TTM): -290.02M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -290.02M |
September 30, 2023 | -307.16M |
June 30, 2023 | -266.02M |
March 31, 2023 | -255.58M |
December 31, 2022 | -301.80M |
Date | Value |
---|---|
September 30, 2022 | -457.71M |
June 30, 2022 | -750.41M |
March 31, 2022 | -783.81M |
December 31, 2021 | -867.42M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-867.42M
Minimum
Dec 2021
-255.58M
Maximum
Mar 2023
-475.55M
Average
-307.16M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
Affimed NV | -119.38M |
InflaRx NV | -40.94M |
MorphoSys AG | -- |
BioNTech SE | 5.815B |
Immatics NV | 19.73M |